Albert Allen

Senior Medical Fellow, Bioethics & Pediatric Capabilities at Eli Lilly and Company

Alex M.

Strategic Business Analyst at Sentry Biopharma Services

Indianapolis Indiana UNITED STATES

Alfredo Fontanini, MD,PhD

Assoc. Professor, Neurobiology & Behavior at SUNY Stony Brook

Caroline D.

Gestionnaire de comptes et coordination at Biron Groupe Santé

Brossard QC CANADA

Chris Garabedian

Chairman and CEO at Xontogeny, LLC

Boston Massachusetts UNITED STATES

Christine Brennan

Partner at Merck MRL Ventures Fund

Kenilworth Kenilworth UNITED STATES

Christopher R.

Scientific Intelligence Lead at Takeda Oncology

Cambridge Massachusetts UNITED STATES

Daniel Anderson

Head of Commercial Partnerships at InVitae Corporation

San Francisco California UNITED STATES

Debbie Allen

Senior Vice President Business Development at arGEN-X

Zwijnaarde-Gent BELGIUM

Dr. Alice Jacobs

Advisor to VC companies at EIR at CalTech

Los Angeles California                   UNITED STATES

Dr. Carsten Brunn

Head of Pharmaceuticals, Americas Region at Bayer

Whippany New Jersey UNITED STATES

Dr. George Vlasuk

CEO at Navitor Pharmaceuticals

Cambridge Massachusetts        UNITED STATES

Dr. James Phillips

Projects Officer, Office of the Principal Assistant for Acquisitions at U.S. Army Medical Research and Materiel Command

Frederick MD UNITED STATES

Dr. Jared Auclair

Director of Executive Training and Biotechnology Programs at Northeastern University

Boston Massachusetts UNITED STATES

Dr. Javier Pedreño, LLM,MD,MSc,PhD

Founder & CEO at Alxerion Biotech Corporation

Cambridge Massachusetts        UNITED STATES

Dr. Lara Sullivan, MBA,MD

President & Founder at SpringWorks Therapeutics

New York New York UNITED STATES

Dr. Leeland Ekstrom, PhD

COO & Founder at Nashville Biosciences

Nashville Tennessee UNITED STATES

Dr. Martin Tolar, MD, PhD

CEO at Alzheon, Inc.

Framingham Massachusetts        UNITED STATES

Dr. Mary Koto, Ph.D., PhD

Managing Partner at Bionest Partners, Inc.

New York New York UNITED STATES

Dr. Michael Altorfer

CEO at Swiss Biotech Association

Zürich SWITZERLAND